Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.

Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X.

Clin Ther. 2014 Mar 1;36(3):385-8. doi: 10.1016/j.clinthera.2014.01.017. Epub 2014 Mar 1.

PMID:
24594069
2.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.

Am J Hematol. 2005 Apr;78(4):275-80.

4.

Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.

Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J; Mexican Hematology Study Group.

Ann Hematol. 2007 Dec;86(12):871-7. Epub 2007 Sep 14.

5.
6.

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.

Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.

Blood. 2008 Aug 15;112(4):999-1004. doi: 10.1182/blood-2008-01-131029. Epub 2008 May 7.

7.

Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.

Schweizer C, Reu FJ, Ho AD, Hensel M.

Ann Hematol. 2007 Oct;86(10):711-7. Epub 2007 Jul 11.

PMID:
17622529
8.

Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.

Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R.

Am J Hematol. 2012 Mar;87(3):321-3. doi: 10.1002/ajh.22266. Epub 2011 Dec 21.

9.

Long-term outcomes in adults with chronic ITP after splenectomy failure.

McMillan R, Durette C.

Blood. 2004 Aug 15;104(4):956-60. Epub 2004 Apr 20.

10.

Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.

Colović M, Suvajdzic N, Colović N, Tomin D, Vidović A, Palibrk V.

Platelets. 2011;22(2):153-6. doi: 10.3109/09537104.2010.520372. Epub 2010 Dec 8.

PMID:
21142405
11.

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.

Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.

Eur J Haematol. 2002 Aug;69(2):95-100.

PMID:
12366712
12.

The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.

Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O.

J Thromb Thrombolysis. 2009 Apr;27(3):329-33. doi: 10.1007/s11239-008-0208-z. Epub 2008 Mar 3.

PMID:
18311541
13.

Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.

Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.

Ann Hematol. 2002 Aug;81(8):436-40. Epub 2002 Jul 26.

PMID:
12224000
14.

Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center.

Ismet A, Irfan K, Emin K, AlI EM, Ramazan U, Mustafa B, Onur O.

Clin Lab Haematol. 2004 Jun;26(3):211-4.

PMID:
15163320
15.

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.

Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR; Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP.

Ann Hematol. 2006 Jun;85(6):400-6. Epub 2006 Mar 21. Erratum in: Ann Hematol. 2006 Aug;85(8):558. Dosage error in article text.

PMID:
16550390
16.

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.

Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB.

Br J Haematol. 2004 Apr;125(2):232-9.

PMID:
15059147
17.

[Treatment outcome of immune thrombocytopenia].

Iványi JL, Marton E, Plander M.

Orv Hetil. 2012 Oct 14;153(41):1613-21. doi: 10.1556/OH.2012.29456. Hungarian.

PMID:
23045311
18.

A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.

Dan K, Gomi S, Kuramoto A, Maekawa T, Nomura T.

Int J Hematol. 1992 Jun;55(3):287-92.

PMID:
1498319
20.

Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.

Johansson E, Engervall P, Landgren O, Grimfors G, Widell S, Rezai S, Björkholm M.

Eur J Haematol. 2006 Jul;77(1):61-6. Epub 2006 Mar 27.

PMID:
16573739
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk